(NYSE:HCN) has issued payments of $0.825 per share to stock holders.  While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. To determine the direction the stock sentiment is headed, it’s noted that the stock had a rating of 2.23 three months ago.

Health Care REIT, Inc. has lost 5.18% in the last five trading days and dropped 1.86% in the last 4 weeks. (NYSE:HCN) is $84.88 and the 52-week low is $62.05. The 52-week low of the share price is $24.01. SunTrust Robinson Humphrey initiates coverage on Health Care REIT, Inc.

Sabra Health Care REIT, Inc. The company has a market cap of $24,076 million and there are 351,885,000 shares in outstanding. Mizuho reiterated a “neutral” rating and issued a $74.00 price objective (down previously from $77.00) on shares of Health Care REIT in a research report on Saturday, May 23rd.

For the current week, the company shares have a recommendation consensus of Buy.

He maintained his $18 price target, which continues to reflect a 25% premium to Canaccord’s forward net asset value and incorporating a 7.2% applied cap rate. The company had a trading volume of 711,110 shares. The 50-day moving average is $68.29 and the 200 day moving average is recorded at $72.35. This is the calculated earnings per share estimate from the 10 polled by Zacks. Health Care REIT, Inc. has dropped 5.69% during the last 3-month period. Health Care REIT’s revenue was up 15.8% on a year-over-year basis.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 20th. Also, EVP Erin C. Ibele sold 550 shares of Health Care REIT stock in a transaction on Monday, July 20th. The ex-dividend date of this dividend was Friday, August 7th. In addition, Forward Management Llc have 2.09% of their US long stock exposure invested in the company for 1.05 million shares. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The stock finished the day down $2.45 per share. The disclosure for this sale can be found here. The stock was sold at an average price of $67.77, for a total value of $67,770.00. The Firm’s portfolio spans the spectrum of seniors housing and health care property, including seniors housing communities, post- acute care facilities, medical office buildings, inpatient and outpatient medical centers and life science facilities.

The Seniors Housing Managing segment’s properties comprise care homes, assisted living facilities, independent living facilities and independent encouraging living facilities and Alzheimer’s/dementia care facilities.


As of March 31, 2014, Sabras investment portfolio consisted of 129 real estate properties held for investment and leased to operators/tenants under triple-net lease agreements, 11 debt investments (consisting of four mortgage loans, three construction loans, one mezzanine loan, and three pre-development loans) and two preferred equity investments. The Medical Facilities segment’s properties include medical office buildings and life science facilities.